Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 11/20 | 0.48 |
| ▸ | NRAS | P01111 | 4/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.36 |
| ▸ | KDR | P35968 | 5/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | CDK7 | P50613 | 1/20 | 0.34 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.34 |
| ▸ | CCNH | P51946 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10238530 | 0.90 | FLT3 (0.53) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL10239886 | 0.90 | FLT3 (0.53) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL10238379 | 0.90 | FLT3 (0.48) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL12553537 | 0.88 | FLT3 (0.47) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL10239824 | 0.86 | IRAK4 (0.51) | FLT3IRAK4 | |
| SCHEMBL10239503 | 0.85 | FLT3 (0.46) | FLT3NRASIRAK4LCKRET | |
| SCHEMBL10239870 | 0.85 | FLT3 (0.56) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL10239866 | 0.84 | FLT3 (0.54) | FLT3NRASIRAK4KDRCSF1R | |
| SCHEMBL10239521 | 0.82 | FLT3 (0.52) | FLT3NRASIRAK4 | |
| SCHEMBL376386 | 0.81 | IRAK4 (0.43) | FLT3NRASIRAK4LCKRET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328890-B1 | 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS | PFIZER (US) | 2012-01-25 | — | — | EP | disclosed |
| WO-2010016005-A1 | 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS | PFIZER INC. (US) | 2010-02-11 | — | — | WO | disclosed |